The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Sara Sefton
Advertisement
Sara Sefton is technical manager, pharmaceutical development, Vectura.
Articles by Sara Sefton
Advertisement
Latest Updated Articles
Integrated Approach Facilitates Inhalation Drug DevelopmentPublished: August 1st 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
CPHI Frankfurt 2025: The Current API Market
5
